Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue ACTA OPHTHALMOLOGICA Année : 2022

Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study

Fichier non déposé

Dates et versions

hal-03955588 , version 1 (25-01-2023)

Identifiants

Citer

Laurent Kodjikian, Amro Abukhashabah, Christine Fardeau, Ramin Tadayoni, Antoine Brezin, et al.. Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study. ACTA OPHTHALMOLOGICA, 2022, ⟨10.1111/aos.15214⟩. ⟨hal-03955588⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More